The soluble VEGFR1 concentration in the serum of patients with colorectal cancer

Associated expression of α2,3sialylated type 2 chain structures with lymph node metastasis in distal colorectal cancer

(2012) Takaharu Fukasawa et al.   SURGERY TODAY

Potential role of soluble VEGFR-1 in antiangiogenesis therapy for cancer

(2011) Feng Yang et al.   Expert Review of Anticancer Therapy

Soluble forms of VEGF receptor-1 and -2 promote vascular maturation via mural cell recruitment

(2010) Sophie Lorquet et al.   FASEB JOURNAL

The molecular therapy of colorectal cancer

(2010) Maximilian J. Waldner et al.   MOLECULAR ASPECTS OF MEDICINE

Phase II Trial of the Combination of Bevacizumab and Erlotinib in Patients Who Have Advanced Hepatocellular Carcinoma

(2009) Melanie B. Thomas et al.   JOURNAL OF CLINICAL ONCOLOGY

Cancer incidence and mortality in Iran

(2008) S. M. Mousavi et al.   ANNALS OF ONCOLOGY

Cancer Statistics, 2008

(2008) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Comparison of serum VEGF and its soluble receptor sVEGFR1 with serum cell-free DNA in patients with breast tumor

(2008) Shereen El Tarhouny et al.   CYTOKINE

High levels of vascular endothelial growth factor and its receptors (VEGFR-1, VEGFR-2, neuropilin-1) are associated with worse outcome in breast cancer

(2008) Sriparna Ghosh et al.   HUMAN PATHOLOGY

The VEGF receptor Flt-1 spatially modulates Flk-1 signaling and blood vessel branching

(2008) Nicholas C. Kappas et al.   JOURNAL OF CELL BIOLOGY

Prognostic and predictive value of vascular endothelial growth factor and its soluble receptors, VEGFR-1 and VEGFR-2 levels in the sera of small cell lung cancer patients

(2008) Zeki Ustuner et al.   MEDICAL ONCOLOGY